Child's sudden death rocks the gene therapy field

The death has sent concern and uncertainty rippling through labs and companies along with rare disease groups.

December 27, 2025 Check out STAT+

Sponsored By

We have a special deal this holiday season: Get 25% off your first year of STAT+. And don't miss the latest installments of our American Science, Shattered series below. Thanks for reading.

FREDERIC J. BROWN/AFP via Getty Images American food safety could be headed for a breakdown Food safety experts say federal cuts this year, including scaled-back FoodNet surveillance, will expose more Americans to foodborne illness. By Sarah Todd SERGEI GAPON/AFP via Getty Images FDA approves pill version of Novo Nordisk's Wegovy, possibly widening access The oral version of the obesity therapy led to similar efficacy as the injectable weight loss treatment in a late-stage clinical trial. By Elaine Chen Molly Ferguson for STAT STAT+ | Opinion: What Ozempic might tell us about the future of Alzheimer's Ozempic has become, like Prozac, a paradigm-shifting drug. What will Alzheimer's iconic drug look like? By Jason Karlawish

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser